Showing 91 - 100 of 118
We examine the effect of competitive shocks on executive compensation in the pharmaceutical sector. When a pharmaceutical firm receives a breakthrough therapy designation (BTD), its rivals respond by increasing option-based compensation for CEOs and other executives. The rivals also escalate...
Persistent link: https://www.econbiz.de/10014237847
Persistent link: https://www.econbiz.de/10008649186
Persistent link: https://www.econbiz.de/10009756844
Persistent link: https://www.econbiz.de/10010410155
Persistent link: https://www.econbiz.de/10010410713
Persistent link: https://www.econbiz.de/10003324529
Persistent link: https://www.econbiz.de/10003941910
Persistent link: https://www.econbiz.de/10011453364
Persistent link: https://www.econbiz.de/10011742054
Persistent link: https://www.econbiz.de/10011800289